WY-14 643 rapidly activates nuclear factor κB in Kupffer cells before hepatocytes

Carcinogenesis

Volumn 19, Issue 7, 1998, Pages 1217-1222

  Rusyn, Ivan ^a   Tsukamoto, Hidekazu ^c   Thurman, Ronald G ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR; PIRINIXIC ACID; SCAVENGER; XANTHINE OXIDASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; INTRAGASTRIC DRUG ADMINISTRATION; KUPFFER CELL; LIVER; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT;

ALLOPURINOL; ANIMALS; ANTIMETABOLITES; CARCINOGENS; CELL DIVISION; DRUG INTERACTIONS; FEMALE; KUPFFER CELLS; LIVER; MICROBODIES; NF-KAPPA B; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031878489     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.7.1217     Document Type: Article

References (37)

1. Baldwin, A.S. (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol., 14, 649-681.
2. Baeuerle, P.A. and Henkel, T. (1994) Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol., 12, 141-179.
3. Siebenlist, U., Franzoso, G. and Brown, K. (1994) Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol., 10, 405-455.
4. Remacle, J., Raes, M., Toussaint, O., Renard, P. and Rao, G. (1995) Low levels of reactive oxygen species as modulators of cell function. Mutat. Res., 316, 103-122.
5. Marsman, D.S., Cattley, R.C., Conway, J.G. and Popp, J.A. (1988) Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14 643) in rats. Cancer Res., 48, 6739-6744.
6. Reddy, J.K. and Lalwani, N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol., 12, 1-58.
7. Reddy, J.K. and Rao, M.S. (1989) Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis. Mutat. Res., 214, 63-68.
8. 2 production by peroxisomes. Eur. J. Biochem., 176, 477-484.
9. Hegi, M.E., Ulrich, D., Sagelsdorff, P., Richter, C. and Lutz, W.K. (1990) No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid low-methionine diet. Mutat. Res., 238, 325-329.
10. Cattley, R.C., Marsmann, D.S. and Popp, J.A. (1991) Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14 643 in rat liver. Carcinogenesis. 12, 469-473.
11. Decker, K. (1990) Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem., 192, 245-261.
12. 2 by rat Kupffer cells. Biol. Chem. Hoppe-Seyler, 372, 829-834.
13. Bojes, H.K. and Thurman, R.G. (1996) Peroxisome proliferators activate Kupffer cells in vivo. Cancer Res., 56, 1-4.
14. Rose, M.L., Germolec, D.R., Schoonhoven, R. and Thurman, R.G. (1997) Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis, 18, 1453-1456.
15. Rose, M.L., Germolec, D., Arteel, G.E., Schoonhoven, R. and Thurman, R.G. (1997) Dietary glycine completely prevents the increase in hepatocyte proliferation caused by the peroxisome proliferator WY-14 643. Chem. Res. Toxicol., 10, 1198-1204.
16. Bojes, H.K., Germolec, D.R., Simeonova, P., Bruccoleri, A., Luster, M.I. and Thurman, R.G. (1997) Antibodies to tumor necrosis factor α prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14 643. Carcinogenesis. 18, 669-674.
17. Li, Y., Leung, L.K., Glauert, H.P. and Spear, B.T. (1996) Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-κB activity. Carcinogenesis, 17, 2305-2309.
18. Menegazzi, M., Carcereri-De Prati, A., Suzuki, H., Shinozuka, H., Pibiri, M., Piga, R., Columbano, A. and Ledda-Columbano, G.M. (1997) Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-κB and AP-1 or with expression of TNF alpha. Hepatology, 25, 585-592.
19. Ohmura, T., Ledda-Columbano, G.M., Piga, R., Columbano, A., Glemba, J., Katyal, S.L., Locker, J. and Shinozuka, H. (1996) Hepatocyte proliferation induced by a single dose of a peroxisome proliferator. Am. J. Pathol., 148, 815-824.
20. Pertoft, H. and Smedsrod, B. (1987) Separation and characterization of liver cells. In Pretlow II, T.G. and Pretlow, T.P. (eds) Cell Separation: Methods and Selected Applications, vol. 4. Academic Press, London, pp. 1-24.
21. Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
22. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
23. 2+ dependence, and differential half-site recognition. J. Biol. Chem., 266, 252-260.
24. Baeuerle, P.A. and Baltimore, D. (1989) A 65-kDa subunit of active NF-κB is required for inhibition of NF-κB by IκB. Genes. Dev., 3, 1689-1698.
25. Moorhouse, P.C., Grootveld, M., Halliwell, B., Quinlan, J.G. and Gutteridge, J.M.C. (1987) Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett., 213, 23-28.
26. Reddy, J.K., Jirtle, R.L., Watanabe, T.K., Reddy, N.K., Michalopoulos, G. and Qureshi, S.A. (1995) Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators. Cancer Res., 44, 2582-2589.
27. Feingold, K.R., Soued, M. and Grunfeld, C. (1988) Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. Biochem. Biophys. Res. Commun., 153, 576-582.
28. Schulte-Hermann, R., Schuppler, J., Timmermann-Trosiener, I., Ohde, G., Bursch, W. and Berger, H. (1983) The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver. Environ. Health Perspect., 50, 185-194.
29. Lake, B.G. (1995) Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annu. Rev. Pharmacol. Toxicol., 35, 483-507.
30. Nishizuka, Y. (1984) The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature, 308, 693-698.
31. Diaz-Meco, M.T., Dominguez, I., Sanz, L., et al. (1994) Zeta PKC induces phosphorylation and inactivation of I kappa B-alpha in vitro. EMBO J., 13, 2842-2848.
32. Flohe, L., Brigelius-Flohe, R., Saliou, C., Traber, M.G. and Packer, L. (1997) Redox regulation of NF-kappa B activation. Free Rad. Biol. Med., 22, 1115-1126.
33. Bojes, H.K. and Thurman, R.G. (1994) Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo. Toxicol. Appl. Pharmacol., 126, 233-239.
34. Nishizuka, Y. (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature, 334, 661-665.
35. Wiezorek, J.S., Brown, D.H., Kupperman, D.E. and Brass, C.A. (1994) Rapid conversion to high xanthine oxidase activity in viable Kupffer cells during hypoxia. J. Clin. Invest., 94, 2224-2230.
36. Grilli, M., Chiou, J.S. and Lenardo, M.J. (1993) NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol., 143, 1-62.
37. Columbano, A. and Shinozuka, H. (1996) Liver regeneration versus direct hyperplasia. FASEB J., 10, 1118-1128.